Back
The Glimpse Group, Inc. Vs. Cidara Therapeutics, Inc. Industry Stock Comparison
Sell
22
VRAR
The Glimpse Group, Inc.
Last Price:
$1.02
Seasonality Move:
-0.01%
Buy
77
CDTX
Cidara Therapeutics, Inc.
Last Price:
$220.65
Seasonality Move:
9.28%
Sell
22
The Glimpse Group, Inc. (VRAR)
is a Sell
Is The Glimpse Group, Inc. a Buy, Sell or Hold?
-
The current The Glimpse Group, Inc. [VRAR] share price is $1.02. The Score for VRAR is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
VRAR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Cidara Therapeutics, Inc. [CDTX] share price is $220.65. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VRAR Stock Price Chart
What is The Glimpse Group, Inc.'s stock price today?
-
The The Glimpse Group, Inc. share price today is $1.02Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRAR is experiencing selling pressure, which indicates risk of future bearish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics, Inc.'s stock price today?
-
The Cidara Therapeutics, Inc. share price today is $220.65Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
VRAR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 38.47 | Sell |
| Chaikin Money Flow: | -111169 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.03 - 1.25) | Sell |
| Bollinger Bands (100): | (1.22 - 1.62) | Sell |
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 21.57 | Buy |
| Relative Strength Index (14 RSI): | 86.06 | Buy |
| Chaikin Money Flow: | 367727 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (151.4 - 242.46) | Buy |
| Bollinger Bands (100): | (51.44 - 167.06) | Buy |
VRAR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.08 | Sell |
| 20-day SMA: | 1.1 | Sell |
| 50-day SMA: | 1.35 | Sell |
| 200-day SMA: | 1.36 | Sell |
| 8-day EMA: | 1.08 | Sell |
| 20-day EMA: | 1.14 | Sell |
| 50-day EMA: | 1.28 | Sell |
| 200-day EMA: | 1.38 | Sell |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 220.33 | Buy |
| 20-day SMA: | 219.69 | Buy |
| 50-day SMA: | 150.04 | Buy |
| 200-day SMA: | 68.84 | Buy |
| 8-day EMA: | 219.45 | Buy |
| 20-day EMA: | 204.15 | Buy |
| 50-day EMA: | 162.92 | Buy |
| 200-day EMA: | 88.08 | Buy |
The Glimpse Group, Inc. Earnings Growth & VRAR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.
The Glimpse Group, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cidara Therapeutics, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||